Adaptive designs in clinical trials: why use them, and how to run and report them
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Adaptive designs in clinical trials: why use them, and how to run and report them
Authors
Keywords
Statistical methods, Adaptive design, Flexible design, Interim analysis, Design modification, Seamless design
Journal
BMC Medicine
Volume 16, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-02-28
DOI
10.1186/s12916-018-1017-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Bayesian clinical trial designs
- (2017) Jan O. Jansen et al. Journal of Trauma and Acute Care Surgery
- Estimation in multi-arm two-stage trials with treatment selection and time-to-event endpoint
- (2017) Matthias Brückner et al. STATISTICS IN MEDICINE
- Bayesian clinical trial designs
- (2017) Jan O. Jansen et al. Journal of Trauma and Acute Care Surgery
- The role of adaptive trial designs in drug development
- (2017) François Curtin et al. Expert Review of Clinical Pharmacology
- Rendering the 3 + 3 Design to Rest: More Efficient Approaches to Oncology Dose-Finding Trials in the Era of Targeted Therapy
- (2016) L. Nie et al. CLINICAL CANCER RESEARCH
- A Study of Donor Ex-Vivo Lung Perfusion in UK Lung Transplantation (DEVELOP-UK)
- (2016) A.J. Fisher et al. JOURNAL OF HEART AND LUNG TRANSPLANTATION
- Data Monitoring Committees — Expect the Unexpected
- (2016) David L. DeMets et al. NEW ENGLAND JOURNAL OF MEDICINE
- Response-adaptive clinical trials: case studies in the medical literature
- (2016) Andrew P. Grieve PHARMACEUTICAL STATISTICS
- Developing a Bayesian adaptive design for a phase I clinical trial: a case study for a novel HIV treatment
- (2016) Alexina J. Mason et al. STATISTICS IN MEDICINE
- Implementation of adaptive methods in early-phase clinical trials
- (2016) Gina R. Petroni et al. STATISTICS IN MEDICINE
- What are the roles and valued attributes of a Trial Steering Committee? Ethnographic study of eight clinical trials facing challenges
- (2016) Anne Daykin et al. Trials
- Attitudes and opinions regarding confirmatory adaptive clinical trials: a mixed methods analysis from the Adaptive Designs Accelerating Promising Trials into Treatments (ADAPT-IT) project
- (2016) William J. Meurer et al. Trials
- Type I error rates of multi-arm multi-stage clinical trials: strong control and impact of intermediate outcomes
- (2016) Daniel J. Bratton et al. Trials
- Adaptive designs undertaken in clinical research: a review of registered clinical trials
- (2016) Isabella Hatfield et al. Trials
- Addressing Challenges and Opportunities of “Less Well-Understood” Adaptive Designs
- (2016) Weili He et al. Therapeutic Innovation & Regulatory Science
- DIA’s Adaptive Design Scientific Working Group (ADSWG)
- (2016) Eva Miller et al. Therapeutic Innovation & Regulatory Science
- Biomarker-Guided Adaptive Trial Designs in Phase II and Phase III: A Methodological Review
- (2016) Miranta Antoniou et al. PLoS One
- Prospective study evaluating the relative sensitivity of18F-NaF PET/CT for detecting skeletal metastases from renal cell carcinoma in comparison to multidetector CT and99mTc-MDP bone scintigraphy, using an adaptive trial design
- (2015) E. L. Gerety et al. ANNALS OF ONCOLOGY
- Trial Steering Committees in randomised controlled trials: A survey of registered clinical trials units to establish current practice and experiences
- (2015) Elizabeth J Conroy et al. Clinical Trials
- Patient-centric trials for therapeutic development in precision oncology
- (2015) Andrew V. Biankin et al. NATURE
- Adaptive sample size modification in clinical trials: start small then ask for more?
- (2015) Christopher Jennison et al. STATISTICS IN MEDICINE
- Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls
- (2015) Peter Bauer et al. STATISTICS IN MEDICINE
- No solution yet for combining two independent studies in the presence of heterogeneity
- (2015) Andrea Gonnermann et al. STATISTICS IN MEDICINE
- Maximum type I error rate inflation from sample size reassessment when investigators are blind to treatment labels
- (2015) Magdalena Żebrowska et al. STATISTICS IN MEDICINE
- Estimation after subpopulation selection in adaptive seamless trials
- (2015) Peter K. Kimani et al. STATISTICS IN MEDICINE
- Missing steps in a staircase: a qualitative study of the perspectives of key stakeholders on the use of adaptive designs in confirmatory trials
- (2015) Munyaradzi Dimairo et al. Trials
- The design of a multi-arm multi-stage (MAMS) phase III randomised controlled trial comparing alternative regimens for escalating (COMPARE) treatment of intermediate and high-risk oropharyngeal cancer with reflections on the complications of introducing a new experimental ARM
- (2015) Piers Gaunt et al. Trials
- A pragmatic approach to the design and calibration of a Bayesian CRM dose finding trial
- (2015) Michael Cole et al. Trials
- Cross-sector surveys assessing perceptions of key stakeholders towards barriers, concerns and facilitators to the appropriate use of adaptive designs in confirmatory trials
- (2015) Munyaradzi Dimairo et al. Trials
- Exploring the role and function of trial steering committees: results of an expert panel meeting
- (2015) Nicola L. Harman et al. Trials
- Telmisartan and Insulin Resistance in HIV (TAILoR): protocol for a dose-ranging phase II randomised open-labelled trial of telmisartan as a strategy for the reduction of insulin resistance in HIV-positive individuals on combination antiretroviral therapy
- (2015) Sudeep P Pushpakom et al. BMJ Open
- Low-dose dexamethasone as a treatment for women with heavy menstrual bleeding: protocol for response-adaptive randomised placebo-controlled dose-finding parallel group trial (DexFEM)
- (2015) P. Warner et al. BMJ Open
- An Investigation of the Shortcomings of the CONSORT 2010 Statement for the Reporting of Group Sequential Randomised Controlled Trials: A Methodological Systematic Review
- (2015) Abigail Stevely et al. PLoS One
- Maximum type 1 error rate inflation in multiarmed clinical trials with adaptive interim sample size modifications
- (2014) Alexandra C. Graf et al. BIOMETRICAL JOURNAL
- Bayesian designs and the control of frequentist characteristics: A practical solution
- (2014) Steffen Ventz et al. BIOMETRICS
- Three steps to writing adaptive study protocols in the early phase clinical development of new medicines
- (2014) Ulrike Lorch et al. BMC Medical Research Methodology
- When is a seamless study desirable? Case studies from different pharmaceutical sponsors
- (2014) Robert L. Cuffe et al. PHARMACEUTICAL STATISTICS
- Predicting clinical trial results based on announcements of interim analyses
- (2014) Kristine R Broglio et al. Trials
- Adaptive clinical trial designs for European marketing authorization: a survey of scientific advice letters from the European Medicines Agency
- (2014) Amelie Elsäßer et al. Trials
- Correcting for multiple-testing in multi-arm trials: is it necessary and is it done?
- (2014) James M S Wason et al. Trials
- Rationale and study design of the Adaptive study of IL-2 dose on regulatory T cells in type 1 diabetes (DILT1D): a non-randomised, open label, adaptive dose finding trial
- (2014) F. Waldron-Lynch et al. BMJ Open
- Adaptive Design
- (2014) Caroline Claire Morgan et al. Therapeutic Innovation & Regulatory Science
- Novel Statistical Designs for Phase I/II and Phase II Clinical Trials With Dose-Finding Objectives
- (2014) Oleksandr Sverdlov et al. Therapeutic Innovation & Regulatory Science
- Conditionally unbiased and near unbiased estimation of the selected treatment mean for multistage drop-the-losers trials
- (2013) Jack Bowden et al. BIOMETRICAL JOURNAL
- A comparison of methods for constructing confidence intervals after phase II/III clinical trials
- (2013) Peter K. Kimani et al. BIOMETRICAL JOURNAL
- Simultaneous confidence intervals that are compatible with closed testing in adaptive designs
- (2013) D. Magirr et al. BIOMETRIKA
- Uptake of novel statistical methods for early-phase clinical studies in the UK public sector
- (2013) Thomas Jaki Clinical Trials
- Adaptive enrichment with subpopulation selection at interim: Methodologies, applications and design considerations
- (2013) Sue-Jane Wang et al. Contemporary Clinical Trials
- Evaluating Many Treatments and Biomarkers in Oncology: A New Design
- (2013) Richard Kaplan et al. JOURNAL OF CLINICAL ONCOLOGY
- A practical guide to Bayesian group sequential designs
- (2013) Thomas Gsponer et al. PHARMACEUTICAL STATISTICS
- Exact inference for adaptive group sequential designs
- (2013) Ping Gao et al. STATISTICS IN MEDICINE
- Empirical Bayes estimation of the selected treatment mean for two-stage drop-the-loser trials: a meta-analytic approach
- (2013) Jack Bowden et al. STATISTICS IN MEDICINE
- Implementation of adaptive dose-finding designs in two early phase haematological trials: clinical, operational, and methodological challenges
- (2013) Christina Yap et al. Trials
- Practical implementation of an adaptive phase I/II design in chronic myeloid leukaemia: evaluating both efficacy and toxicity using the EffTox design
- (2013) Josephine Khan et al. Trials
- Impact of lack-of-benefit stopping rules on treatment effect estimates of two-arm multi-stage (TAMS) trials with time to event outcome
- (2013) Babak Choodari-Oskooei et al. Trials
- Similarities and Differences of Bayesian Designs and Adaptive Designs for Medical Devices: A Regulatory View
- (2013) Gregory Campbell Statistics in Biopharmaceutical Research
- Unblinded Adaptive Statistical Information Design Based on Clinical Endpoint or Biomarker
- (2013) Sue-Jane Wang* et al. Statistics in Biopharmaceutical Research
- Views on Emerging Issues Pertaining to Data Monitoring Committees for Adaptive Trials
- (2013) Zoran Antonijevic et al. Therapeutic Innovation & Regulatory Science
- A Practical Guide to Data Monitoring Committees in Adaptive Trials
- (2013) Matilde Sanchez-Kam et al. Therapeutic Innovation & Regulatory Science
- A generalized Dunnett test for multi-arm multi-stage clinical studies with treatment selection
- (2012) D. Magirr et al. BIOMETRIKA
- Efficacy and tolerability of rizatriptan in pediatric migraineurs: Results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design
- (2012) Tony W Ho et al. CEPHALALGIA
- Planning and Executing Response-Adaptive Learn-Phase Clinical Trials: 2. Case Studies
- (2012) Parvin Fardipour et al. DRUG INFORMATION JOURNAL
- On the Independence of Data Monitoring Committee in Adaptive Design Clinical Trials
- (2012) Shein-Chung Chow et al. Journal of Biopharmaceutical Statistics
- Adaptive blinded sample size adjustment for comparing two normal means-a mostly Bayesian approach
- (2012) Andrew M. Hartley PHARMACEUTICAL STATISTICS
- Identifying combined design and analysis procedures in two-stage trials with a binary end point
- (2012) Jack Bowden et al. STATISTICS IN MEDICINE
- Shrinkage estimation in two-stage adaptive designs with midtrial treatment selection
- (2012) Máximo Carreras et al. STATISTICS IN MEDICINE
- Practical guidelines for adaptive seamless phase II/III clinical trials that use Bayesian methods
- (2012) Peter K. Kimani et al. STATISTICS IN MEDICINE
- A novel Phase I/IIa design for early phase oncology studies and its application in the evaluation of MK-0752 in pancreatic cancer
- (2012) John Whitehead et al. STATISTICS IN MEDICINE
- A Bayesian-frequentist two-stage single-arm phase II clinical trial design
- (2012) Gaohong Dong et al. STATISTICS IN MEDICINE
- A group sequential Holm procedure with multiple primary endpoints
- (2012) Yining Ye et al. STATISTICS IN MEDICINE
- Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trial
- (2012) Matthew R Sydes et al. Trials
- Group Sequential Methods and Software Applications
- (2011) Li Zhu et al. AMERICAN STATISTICIAN
- The practical application of adaptive study design in early phase clinical trials: a retrospective analysis of time savings
- (2011) U. Lorch et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Regulatory Perspectives on Multiplicity in Adaptive Design Clinical Trials throughout a Drug Development Program
- (2011) Sue-Jane Wang et al. Journal of Biopharmaceutical Statistics
- Maximum inflation of the type 1 error rate when sample size and allocation rate are adapted in a pre-planned interim look
- (2011) Alexandra C. Graf et al. STATISTICS IN MEDICINE
- Bayesian adaptive clinical trials: a dream for statisticians only?
- (2011) Sylvie Chevret STATISTICS IN MEDICINE
- Barriers and opportunities for implementation of adaptive designs in pharmaceutical product development
- (2010) Judith Quinlan et al. Clinical Trials
- Bias and Trials Stopped Early for Benefit
- (2010) Susan S. Ellenberg JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Type I error rate control in adaptive designs for confirmatory clinical trials with treatment selection at interim
- (2010) Martin Posch et al. PHARMACEUTICAL STATISTICS
- Seamless phase II/III designs
- (2010) Nigel Stallard et al. STATISTICAL METHODS IN MEDICAL RESEARCH
- Testing for qualitative interactions between stages in an adaptive study
- (2010) Robert A. Parker STATISTICS IN MEDICINE
- An exact method for analysis following a two-stage phase II cancer clinical trial
- (2010) Gordana Jovic et al. STATISTICS IN MEDICINE
- Adaptive increase in sample size when interim results are promising: A practical guide with examples
- (2010) Cyrus R. Mehta et al. STATISTICS IN MEDICINE
- Dose Escalation Methods in Phase I Cancer Clinical Trials
- (2009) Christophe Le Tourneau et al. JNCI-Journal of the National Cancer Institute
- What should be the role of homogeneity testing in adaptive trials?
- (2009) Paul Gallo et al. PHARMACEUTICAL STATISTICS
- Adaptive designs for confirmatory clinical trials
- (2009) Frank Bretz et al. STATISTICS IN MEDICINE
- Issues in applying multi-arm multi-stage methodology to a clinical trial in prostate cancer: the MRC STAMPEDE trial
- (2009) Matthew R Sydes et al. Trials
- Unbiased Estimation of Selected Treatment Means in Two-Stage Trials
- (2008) Jack Bowden et al. BIOMETRICAL JOURNAL
- Maintaining confidentiality of interim data to enhance trial integrity and credibility
- (2008) Thomas R Fleming et al. Clinical Trials
- Speeding up the Evaluation of New Agents in Cancer
- (2008) M. K. B. Parmar et al. JNCI-Journal of the National Cancer Institute
- Adaptive design methods in clinical trials – a review
- (2008) Shein-Chung Chow et al. Orphanet Journal of Rare Diseases
- Exploring changes in treatment effects across design stages in adaptive trials
- (2008) Tim Friede et al. PHARMACEUTICAL STATISTICS
- Adaptive Clinical Trials
- (2008) Christopher S Coffey et al. Drugs in research & development
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now